China Universal Asset Management Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 53,708 shares of IOVA stock, worth $396,902. This represents 0.1% of its overall portfolio holdings.
Number of Shares
53,708
Previous 53,708
-0.0%
Holding current value
$396,902
Previous $796,000
0.13%
% of portfolio
0.1%
Previous 0.1%
Shares
12 transactions
Others Institutions Holding IOVA
# of Institutions
304Shares Held
221MCall Options Held
3.05MPut Options Held
1.6M-
Vanguard Group Inc Valley Forge, PA24.9MShares$184 Million0.01% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$177 Million40.86% of portfolio
-
Black Rock Inc. New York, NY19.9MShares$147 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY19.3MShares$142 Million5.99% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.7MShares$86.5 Million2.09% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.17B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...